- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine signaling in multiple sclerosis: Lost in translation
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 24, Issue 4, Pages 432-439
Publisher
SAGE Publications
Online
2018-03-07
DOI
10.1177/1352458518763094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System
- (2017) Sabine Spath et al. IMMUNITY
- IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis
- (2017) Jin Kyeong Choi et al. Frontiers in Immunology
- The role of interleukin-6 signaling in nervous tissue
- (2016) Michelle Rothaug et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- IL‐1 signaling is critical for expansion but not generation of autoreactive GM‐CSF + Th17 cells
- (2016) Ilgiz A Mufazalov et al. EMBO JOURNAL
- Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
- (2016) Eva Havrdová et al. JOURNAL OF NEUROLOGY
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- Tocilizumab, MS, and NMOSD
- (2016) Ingo Kleiter et al. Multiple Sclerosis Journal
- Th9 cells in the pathogenesis of EAE and multiple sclerosis
- (2016) Wassim Elyaman et al. Seminars in Immunopathology
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- Tocilizumab, MS, and NMOSD
- (2016) Ingo Kleiter et al. Multiple Sclerosis Journal
- Daclizumab high-yield process in the treatment of relapsing–remitting multiple sclerosis
- (2016) Jana Lizrova Preiningerova et al. Therapeutic Advances in Neurological Disorders
- Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease
- (2015) Lin Sun et al. CYTOKINE
- The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
- (2015) Andrew L. Croxford et al. IMMUNITY
- Interleukin-17- and interleukin-22-secreting myelin-specific CD4+T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients
- (2015) Ana Cristina Wing et al. IMMUNOLOGY
- Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
- (2015) Javad Rasouli et al. JOURNAL OF IMMUNOLOGY
- IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis
- (2015) Ghasem Ghalamfarsa et al. Journal of Immunotoxicology
- The therapeutic potential of interleukin-10 in neuroimmune diseases
- (2015) A.J. Kwilasz et al. NEUROPHARMACOLOGY
- TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
- (2015) L. Probert NEUROSCIENCE
- Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
- (2015) Yonghao Cao et al. Science Translational Medicine
- Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis
- (2014) Aimin Wu et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects
- (2014) Mansour Shajarian et al. IMMUNOLOGICAL INVESTIGATIONS
- Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
- (2014) I. L. Campbell et al. JOURNAL OF NEUROSCIENCE
- Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6
- (2013) Mercedes Giralt et al. GLIA
- Dual role of Response gene to complement-32 in multiple sclerosis
- (2012) Cosmin A. Tegla et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
- (2011) Roberta Brambilla et al. BRAIN
- The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination
- (2011) Volker Limmroth et al. Therapeutic Advances in Neurological Disorders
- Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
- (2010) Amy E. Lovett-Racke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cytokine networks in multiple sclerosis: lost in translation
- (2010) Laura Codarri et al. CURRENT OPINION IN NEUROLOGY
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo
- (2009) Mandy J McGeachy et al. NATURE IMMUNOLOGY
- Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System
- (2008) Marco Prinz et al. IMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now